Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity

Cytidine (C) to Uridine (U) RNA editing is a post-transcription modification that is involved in diverse biological processes. APOBEC1 (A1) catalyzes the conversion of C-to-U in RNA, which is important in regulating cholesterol metabolism through its editing activity on ApoB mRNA. However, A1 requir...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular biology Vol. 435; no. 24; p. 168333
Main Authors Wang, Shanshan, Kim, Kyumin, Gelvez, Nicolas, Chung, Claire, Gout, Jean-Francois, Fixman, Benjamin, Vermulst, Marc, Chen, Xiaojiang S
Format Journal Article
LanguageEnglish
Published Netherlands 15.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cytidine (C) to Uridine (U) RNA editing is a post-transcription modification that is involved in diverse biological processes. APOBEC1 (A1) catalyzes the conversion of C-to-U in RNA, which is important in regulating cholesterol metabolism through its editing activity on ApoB mRNA. However, A1 requires a cofactor to form an "editosome" for RNA editing activity. A1CF and RBM47, both RNA-binding proteins, have been identified as cofactors that pair with A1 to form editosomes and edit ApoB mRNA and other cellular RNAs. SYNCRIP is another RNA-binding protein that has been reported as a potential regulator of A1, although it is not directly involved in A1 RNA editing activity. Here, we describe the identification and characterization of a novel cofactor, RBM46 (RNA-Binding-Motif-protein-46), that can facilitate A1 to perform C-to-U editing on ApoB mRNA. Additionally, using the low-error circular RNA sequencing technique, we identified novel cellular RNA targets for the A1/RBM46 editosome. Our findings provide further insight into the complex regulatory network of RNA editing and the potential new function of A1 with its cofactors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2836
1089-8638
1089-8638
DOI:10.1016/j.jmb.2023.168333